Citadel Advisors’s NeueHealth NEUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-13
Closed -$220 15367
2023
Q1
$220 Sell
13
-92
-88% -$4.74K ﹤0.01% 14545
2022
Q4
$5.46K Buy
+105
New +$7.63K ﹤0.01% 13997
2022
Q2
Sell
-375
Closed -$58K 14277
2022
Q1
$58K Sell
375
-753
-67% -$167K ﹤0.01% 12699
2021
Q4
$310K Buy
1,128
+199
+21% +$91.9K ﹤0.01% 10856
2021
Q3
$606K Buy
+929
New +$817K ﹤0.01% 9400

Other funds holding NEUE

Citadel Advisors's NEUE Position: Q1 2023 in Review

Citadel Advisors sold out of NeueHealth (NEUE) in Q1 2023, closing a stake of 60 shares — an estimated $3.09K sold.

Citadel Advisors first reported a position in NEUE in Q2 2021 and held it in 6 quarters. The position peaked at $53.3M in Q2 2021. 108 funds tracked by Wall St. Rank hold NEUE as of Q1 2023.

  • Citadel Advisors reported no remaining NeueHealth position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 60 NeueHealth shares in Q1 2023, an estimated $3.09K.
  • Citadel Advisors first reported a position in NeueHealth in Q2 2021 and held it in 6 quarters.
  • Citadel Advisors's NeueHealth position peaked at $53.3M in Q2 2021.
  • 108 funds tracked by Wall St. Rank held NeueHealth as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.